Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 3Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3

Conditions

Neurofibromatosis 1 3Prostatic Neoplasms 1Precancerous Conditions 1Melanoma 1Inhibition, Psychological 1Autism Spectrum Disorder 1

Interventions

Lovastatin 3Deoxycholic Acid 3AZD 6244 3pirfenidone 2Vinblastine 2Transcranial Direct Current Stimulation 2Sirolimus 2Polidocanol 2Lasers, Solid-State 2Inhalation 2Acetylcysteine 2tipifarnib 1pomalidomide 1peginterferon alfa-2b 1mirdametinib 1diphenylcyclopropenone 1binimetinib 1X-Rays 1Vincristine 1Temozolomide 1Surveys and Questionnaires 1Sunitinib 1Specimen Handling 1Sorafenib 1Saline Solution 1Ranibizumab 1Radiotherapy 1Photons 1Pharmacokinetics 1Neuropsychological Tests 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Neurofibromatosis 1 × Lovastatin × Clear all
NCT03826940 2021-04-02

ASD/NF1inhib

University of Coimbra

Phase NA Completed
16 enrolled
CNS

Autism Spectrum Disorder, Inhibition, Psychological, Neurofibromatosis 1

NCT00853580 2018-03-12

STARS

University of Alabama at Birmingham

Phase 2 Completed
146 enrolled 29 charts
CNS

Neurofibromatosis 1

NCT00352599 2016-11-22

NF1

University of California, Los Angeles

Phase 1 Completed
44 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡